ArticleJACC. Case reports2026
Percutaneous Patent Foramen Ovale Closure and Aneurysm Elimination by Direct Suture.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPatent foramen ovale (PFO) with significant atrial septal aneurysm (ASA) may pose technical challenges. In selected cases, direct-suture closure may represent an effective alternative to close the PFO and reduce aneurysmal redundancy. CASE SUMMARY: A 54-year-old woman with recurrent transient ischemic episodes and hyperintensity changes on magnetic resonance imaging was referred for percutaneous PFO closure. Transesophageal echocardiography demonstrated right-to-left shunt and markedly aneurysmal interatrial septum with constant rightward displacement. Under echocardiographic guidance, the septum was displaced leftward using a transseptal sheath, allowing wire passage. The PFO was subsequently closed with direct sutures, eliminating the ASA by creating a loop on the right atrial side. DISCUSSION: Direct-suture closure can be considered even in the presence of large ASA, as it not only allows effective PFO closure but also reduction of aneurysmal redundancy. TAKE-HOME MESSAGE: Direct-suture percutaneous PFO closure can successfully and safely be performed in patients with ASA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.